Pennant Group EBIT

Pennant Group (PNTG) currently reports a EBIT of $51M as of June 2026. That compares with $35M in the prior-year period — up 43.9% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Pennant Group's EBIT history and peer comparisons.

Pennant Group's EBIT increased from $35M to $51M — a 43.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pennant Group's EBIT of $51M is lower than the Healthcare sector average of $23B. That is roughly 99.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Pennant Group reported $51M in EBIT as of June 2026. That compares with $35M in the prior-year period — up 43.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $51M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Pennant Group, and consider following PNTG for alerts when major investors trade the stock.